Fever, a common symptom in clinical practice, often presents a diagnostic challenge due to its non-specific nature and wide range of potential etiologies. This article aims to provide a systematic approach to the evaluation and management of fevers in the clinical setting.
The initial assessment of a patient with fever should include a thorough history and physical examination. Clinicians should consider the duration, pattern, and associated symptoms of the fever. The patient's travel history, medication use, and potential exposure to infectious agents should also be evaluated.
Depending on the initial assessment, laboratory and imaging studies may be necessary. Basic tests might include a complete blood count, blood cultures, urine analysis, and chest radiograph. More specific tests, such as serologic assays or PCR, may be required based on the suspected etiology.
While infectious diseases are the most common cause of fever, non-infectious causes, including malignancies and autoimmune diseases, should also be considered. In cases where the cause of fever remains elusive after initial evaluation, a more detailed investigation may be necessary.
The treatment of fever should be guided by the underlying cause. Empirical antimicrobial therapy may be appropriate in certain situations, but should be reassessed as additional information becomes available. In cases of non-infectious fever, treatment should target the underlying disease process.
Fever presents a diagnostic dilemma in clinical practice due to its broad differential diagnosis. A systematic approach to the evaluation and management of fever can facilitate the identification of the underlying cause and guide appropriate treatment. Continuous education and up-to-date knowledge about the potential etiologies of fever are essential for healthcare professionals to provide optimal patient care.
1.
FDA Declines to Approve Achieve Life Sciences' Smoking-cessation Drug
2.
Uncovered biology underlies a novel drug used to treat triple-negative breast cancer.
3.
Chemotherapy damage to non-cancer cells may be the cause of breast cancer recurrence.
4.
Never in a million years did I think I'd have to limit my chemotherapy.
5.
Treating Depression: Crucial for Recovery From Fibromyalgia
1.
HCC in Melanoma: Role of HCC Codes and Moderate Whole Body Hyperthermia
2.
Clinical Analysis of Prostate Cancer
3.
Sorafenib: Understanding the science behind a powerful cancer drug
4.
Early-Onset GI Cancers: Screening, AI Innovations & Research Advances 2025
5.
Comprehensive Breakthroughs in Oncology for Better Care
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Understanding the Evolution in Lung Cancer- An Initiative from Manipal Hospitals: Further Discussion
2.
Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL
3.
A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
4.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
5.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation